Global CRO in Clinical Trials Market Insights, Forecast to 2030

Industry: Medical Devices & Consumables

Published: 2024-11-19

Pages: 141 Pages

Report ld: 3382218

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global CRO in Clinical Trials market is projected to grow from US$ 51240 million in 2024 to US$ 88230 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.5% during the forecast period.

A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries. Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others. In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor’s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).

CRO in Clinical Trials Market Size

M= millions and B=billions

Global core CRO in clinical trials players include Labcorp, IQVIA and Parexel etc. The top 5 companies hold a share about 40%. North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 35% and 20%. In terms of product, phase iii trial is the largest segment, with a share about 35%. And in terms ofend users, the largest end user is pharmaceutical，with a share about 55%.

The market for Contract Research Organizations (CROs) in clinical trials is experiencing significant growth and evolution due to various factors:
Biopharmaceutical Companies: Many pharma and biotech firms are increasingly outsourcing clinical trials to CROs to reduce costs, improve efficiency, and tap into specialized expertise. This trend is particularly notable among smaller biotech companies with limited infrastructure.

Focus on Core Competencies: Large pharmaceutical companies prefer focusing on core R&D activities, delegating clinical trial processes to CROs for scalability and cost-effectiveness.

Decentralized Clinical Trials (DCTs): CROs are innovating with decentralized trial models, enabling remote patient monitoring and data collection. This trend has accelerated post-COVID-19, enhancing patient recruitment, retention, and trial accessibility.

Adaptive and Hybrid Trials: The need for quicker, adaptable trials that can respond to real-time data is driving hybrid and adaptive trial designs. CROs are investing in capabilities to support these complex trial models.

Expanding Trials in APAC and LATAM: CROs are increasingly establishing operations in Asia-Pacific, Latin America, and Eastern Europe, where costs are lower, and recruitment pools are larger.

Regulatory Alignment: Many countries are harmonizing their regulatory requirements with global standards, making it easier for CROs to conduct trials internationally.

Artificial Intelligence (AI) and Machine Learning (ML): CROs are adopting AI/ML for predictive modeling, patient recruitment, trial monitoring, and data analysis, increasing accuracy and efficiency.

Digital Health Technologies: Wearable devices and digital health tools for real-time data capture are becoming integral in trials, supporting both remote and hybrid trial models.

Specialized Trials: Growth in oncology and rare disease research, which often require specialized trial designs and complex patient recruitment, is pushing CROs to develop niche expertise.

Patient-Centric Approaches: CROs are focusing on patient-centric methods to enhance participation and retention, especially in studies with rare or hard-to-reach patient populations.

Compliance and Quality Control: As regulations become more stringent, CROs are enhancing their quality assurance programs to ensure compliance with Good Clinical Practice (GCP) and international standards.

Data Security and Privacy: CROs are also adapting to increased demands for data privacy, especially with the rise in remote and decentralized trials.

Report Includes
This report presents an overview of global market for CRO in Clinical Trials market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of CRO in Clinical Trials, also provides the revenue of main regions and countries. of the upcoming market potential for CRO in Clinical Trials, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the CRO in Clinical Trials revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global CRO in Clinical Trials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for CRO in Clinical Trials revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, Medpace Holdings, Wuxi Apptec, Tigermed, etc.

Market Segmentation

Report Metric
Details
Report Title
Global CRO in Clinical Trials Market Insights, Forecast to 2030
Forecasted Market Size in 2030
US$ 88230 million
CAGR(2024-2030)
9.5%
Market Size Available for Years
2019-2030
Global CRO in Clinical Trials Companies Covered
Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, Medpace Holdings, Wuxi Apptec, Tigermed, Boji Medical Technology, Pharmaron
Global CRO in Clinical Trials Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global CRO in Clinical Trials Market, Segment by Type
Phase I Trial

Phase II Trial

Phase III Trial

Phase IV Trial
Global CRO in Clinical Trials Market, Segment by Application
Pharmaceutical

Bio-pharm

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of CRO in Clinical Trials in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRO in Clinical Trials companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CRO in Clinical Trials revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CRO in Clinical Trials Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
        1.2.2 Phase I Trial
        1.2.3 Phase II Trial
        1.2.4 Phase III Trial
        1.2.5 Phase IV Trial
    1.3 Market by Application
        1.3.1 Global CRO in Clinical Trials Market Share by Application: 2019 VS 2023 VS 2030
        1.3.2 Pharmaceutical
        1.3.3 Bio-pharm
        1.3.4 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global CRO in Clinical Trials Market Perspective (2019-2030)
    2.2 Global CRO in Clinical Trials Growth Trends by Region
        2.2.1 Global CRO in Clinical Trials Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 CRO in Clinical Trials Historic Market Size by Region (2019-2024)
        2.2.3 CRO in Clinical Trials Forecasted Market Size by Region (2025-2030)
    2.3 CRO in Clinical Trials Market Dynamics
        2.3.1 CRO in Clinical Trials Industry Trends
        2.3.2 CRO in Clinical Trials Market Drivers
        2.3.3 CRO in Clinical Trials Market Challenges
        2.3.4 CRO in Clinical Trials Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Revenue CRO in Clinical Trials by Players
        3.1.1 Global CRO in Clinical Trials Revenue by Players (2019-2024)
        3.1.2 Global CRO in Clinical Trials Revenue Market Share by Players (2019-2024)
    3.2 Global CRO in Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players of CRO in Clinical Trials, Ranking by Revenue, 2022 VS 2023 VS 2024
    3.4 Global CRO in Clinical Trials Market Concentration Ratio
        3.4.1 Global CRO in Clinical Trials Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CRO in Clinical Trials Revenue in 2023
    3.5 Global Key Players of CRO in Clinical Trials Head office and Area Served
    3.6 Global Key Players of CRO in Clinical Trials, Product and Application
    3.7 Global Key Players of CRO in Clinical Trials, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

 4 CRO in Clinical Trials Breakdown Data by Type
    4.1 Global CRO in Clinical Trials Historic Market Size by Type (2019-2024)
    4.2 Global CRO in Clinical Trials Forecasted Market Size by Type (2025-2030)

 5 CRO in Clinical Trials Breakdown Data by Application
    5.1 Global CRO in Clinical Trials Historic Market Size by Application (2019-2024)
    5.2 Global CRO in Clinical Trials Forecasted Market Size by Application (2025-2030)

 6 North America
    6.1 North America CRO in Clinical Trials Market Size (2019-2030)
    6.2 North America CRO in Clinical Trials Market Size by Type
        6.2.1 North America CRO in Clinical Trials Market Size by Type (2019-2024)
        6.2.2 North America CRO in Clinical Trials Market Size by Type (2025-2030)
        6.2.3 North America CRO in Clinical Trials Market Share by Type (2019-2030)
    6.3 North America CRO in Clinical Trials Market Size by Application
        6.3.1 North America CRO in Clinical Trials Market Size by Application (2019-2024)
        6.3.2 North America CRO in Clinical Trials Market Size by Application (2025-2030)
        6.3.3 North America CRO in Clinical Trials Market Share by Application (2019-2030)
    6.4 North America CRO in Clinical Trials Market Size by Country
        6.4.1 North America CRO in Clinical Trials Market Size by Country: 2019 VS 2023 VS 2030
        6.4.2 North America CRO in Clinical Trials Market Size by Country (2019-2024)
        6.4.3 North America CRO in Clinical Trials Market Share by Country (2025-2030)
        6.4.4 United States
        6.4.5 Canada

 7 Europe
    7.1 Europe CRO in Clinical Trials Market Size (2019-2030)
    7.2 Europe CRO in Clinical Trials Market Size by Type
        7.2.1 Europe CRO in Clinical Trials Market Size by Type (2019-2024)
        7.2.2 Europe CRO in Clinical Trials Market Size by Type (2025-2030)
        7.2.3 Europe CRO in Clinical Trials Market Share by Type (2019-2030)
    7.3 Europe CRO in Clinical Trials Market Size by Application
        7.3.1 Europe CRO in Clinical Trials Market Size by Application (2019-2024)
        7.3.2 Europe CRO in Clinical Trials Market Size by Application (2025-2030)
        7.3.3 Europe CRO in Clinical Trials Market Share by Application (2019-2030)
    7.4 Europe CRO in Clinical Trials Market Size by Country
        7.4.1 Europe CRO in Clinical Trials Market Size by Country: 2019 VS 2023 VS 2030
        7.4.2 Europe CRO in Clinical Trials Market Size by Country (2019-2024)
        7.4.3 Europe CRO in Clinical Trials Market Size by Country (2025-2030)
        7.4.4 Germany
        7.4.5 France
        7.4.6 U.K.
        7.4.7 Italy
        7.4.8 Russia
        7.4.9 Nordic Countries

 8 China
    8.1 China CRO in Clinical Trials Market Size (2019-2030)
    8.2 China CRO in Clinical Trials Market Size by Type
        8.2.1 China CRO in Clinical Trials Market Size by Type (2019-2024)
        8.2.2 China CRO in Clinical Trials Market Size by Type (2025-2030)
        8.2.3 China CRO in Clinical Trials Market Share by Type (2019-2030)
    8.3 China CRO in Clinical Trials Market Size by Application
        8.3.1 China CRO in Clinical Trials Market Size by Application (2019-2024)
        8.3.2 China CRO in Clinical Trials Market Size by Application (2025-2030)
        8.3.3 China CRO in Clinical Trials Market Share by Application (2019-2030)

 9 Asia (excluding China)
    9.1 Asia CRO in Clinical Trials Market Size (2019-2030)
    9.2 Asia CRO in Clinical Trials Market Size by Type
        9.2.1 Asia CRO in Clinical Trials Market Size by Type (2019-2024)
        9.2.2 Asia CRO in Clinical Trials Market Size by Type (2025-2030)
        9.2.3 Asia CRO in Clinical Trials Market Share by Type (2019-2030)
    9.3 Asia CRO in Clinical Trials Market Size by Application
        9.3.1 Asia CRO in Clinical Trials Market Size by Application (2019-2024)
        9.3.2 Asia CRO in Clinical Trials Market Size by Application (2025-2030)
        9.3.3 Asia CRO in Clinical Trials Market Share by Application (2019-2030)
    9.4 Asia CRO in Clinical Trials Market Size by Region
        9.4.1 Asia CRO in Clinical Trials Market Size by Region: 2019 VS 2023 VS 2030
        9.4.2 Asia CRO in Clinical Trials Market Size by Region (2019-2024)
        9.4.3 Asia CRO in Clinical Trials Market Size by Region (2025-2030)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India
        9.4.9 Australia

 10 Middle East, Africa, and Latin America
    10.1 Middle East, Africa, and Latin America CRO in Clinical Trials Market Size (2019-2030)
    10.2 Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Type
        10.2.1 Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Type (2019-2024)
        10.2.2 Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Type (2025-2030)
        10.2.3 Middle East, Africa, and Latin America CRO in Clinical Trials Market Share by Type (2019-2030)
    10.3 Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Application
        10.3.1 Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Application (2019-2024)
        10.3.2 Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Application (2025-2030)
        10.3.3 Middle East, Africa, and Latin America CRO in Clinical Trials Market Share by Application (2019-2030)
    10.4 Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Country
        10.4.1 Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Country: 2019 VS 2023 VS 2030
        10.4.2 Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Country (2019-2024)
        10.4.3 Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Country (2025-2030)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Saudi Arabia
        10.4.8 Israel
        10.4.9 GCC Countries

 11 Key Players Profiles
    11.1 Labcorp
        11.1.1 Labcorp Company Details
        11.1.2 Labcorp Business Overview
        11.1.3 Labcorp CRO in Clinical Trials Introduction
        11.1.4 Labcorp Revenue in CRO in Clinical Trials Business (2019-2024)
        11.1.5 Labcorp Recent Development
    11.2 IQVIA
        11.2.1 IQVIA Company Details
        11.2.2 IQVIA Business Overview
        11.2.3 IQVIA CRO in Clinical Trials Introduction
        11.2.4 IQVIA Revenue in CRO in Clinical Trials Business (2019-2024)
        11.2.5 IQVIA Recent Development
    11.3 Parexel
        11.3.1 Parexel Company Details
        11.3.2 Parexel Business Overview
        11.3.3 Parexel CRO in Clinical Trials Introduction
        11.3.4 Parexel Revenue in CRO in Clinical Trials Business (2019-2024)
        11.3.5 Parexel Recent Development
    11.4 Syneos Health
        11.4.1 Syneos Health Company Details
        11.4.2 Syneos Health Business Overview
        11.4.3 Syneos Health CRO in Clinical Trials Introduction
        11.4.4 Syneos Health Revenue in CRO in Clinical Trials Business (2019-2024)
        11.4.5 Syneos Health Recent Development
    11.5 PRA Health Sciences
        11.5.1 PRA Health Sciences Company Details
        11.5.2 PRA Health Sciences Business Overview
        11.5.3 PRA Health Sciences CRO in Clinical Trials Introduction
        11.5.4 PRA Health Sciences Revenue in CRO in Clinical Trials Business (2019-2024)
        11.5.5 PRA Health Sciences Recent Development
    11.6 PPD
        11.6.1 PPD Company Details
        11.6.2 PPD Business Overview
        11.6.3 PPD CRO in Clinical Trials Introduction
        11.6.4 PPD Revenue in CRO in Clinical Trials Business (2019-2024)
        11.6.5 PPD Recent Development
    11.7 ICON
        11.7.1 ICON Company Details
        11.7.2 ICON Business Overview
        11.7.3 ICON CRO in Clinical Trials Introduction
        11.7.4 ICON Revenue in CRO in Clinical Trials Business (2019-2024)
        11.7.5 ICON Recent Development
    11.8 Medpace Holdings
        11.8.1 Medpace Holdings Company Details
        11.8.2 Medpace Holdings Business Overview
        11.8.3 Medpace Holdings CRO in Clinical Trials Introduction
        11.8.4 Medpace Holdings Revenue in CRO in Clinical Trials Business (2019-2024)
        11.8.5 Medpace Holdings Recent Development
    11.9 Wuxi Apptec
        11.9.1 Wuxi Apptec Company Details
        11.9.2 Wuxi Apptec Business Overview
        11.9.3 Wuxi Apptec CRO in Clinical Trials Introduction
        11.9.4 Wuxi Apptec Revenue in CRO in Clinical Trials Business (2019-2024)
        11.9.5 Wuxi Apptec Recent Development
    11.10 Tigermed
        11.10.1 Tigermed Company Details
        11.10.2 Tigermed Business Overview
        11.10.3 Tigermed CRO in Clinical Trials Introduction
        11.10.4 Tigermed Revenue in CRO in Clinical Trials Business (2019-2024)
        11.10.5 Tigermed Recent Development
    11.11 Boji Medical Technology
        11.11.1 Boji Medical Technology Company Details
        11.11.2 Boji Medical Technology Business Overview
        11.11.3 Boji Medical Technology CRO in Clinical Trials Introduction
        11.11.4 Boji Medical Technology Revenue in CRO in Clinical Trials Business (2019-2024)
        11.11.5 Boji Medical Technology Recent Development
    11.12 Pharmaron
        11.12.1 Pharmaron Company Details
        11.12.2 Pharmaron Business Overview
        11.12.3 Pharmaron CRO in Clinical Trials Introduction
        11.12.4 Pharmaron Revenue in CRO in Clinical Trials Business (2019-2024)
        11.12.5 Pharmaron Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global CRO in Clinical Trials Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Phase I Trial
 Table 3. Key Players of Phase II Trial
 Table 4. Key Players of Phase III Trial
 Table 5. Key Players of Phase IV Trial
 Table 6. Global CRO in Clinical Trials Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global CRO in Clinical Trials Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global CRO in Clinical Trials Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global CRO in Clinical Trials Market Share by Region (2019-2024)
 Table 10. Global CRO in Clinical Trials Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global CRO in Clinical Trials Market Share by Region (2025-2030)
 Table 12. CRO in Clinical Trials Market Trends
 Table 13. CRO in Clinical Trials Market Drivers
 Table 14. CRO in Clinical Trials Market Challenges
 Table 15. CRO in Clinical Trials Market Restraints
 Table 16. Global CRO in Clinical Trials Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global CRO in Clinical Trials Market Share by Players (2019-2024)
 Table 18. Global Top CRO in Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRO in Clinical Trials as of 2023)
 Table 19. Global CRO in Clinical Trials Industry Ranking 2022 VS 2023
 Table 20. Global 5 Largest Players Market Share by CRO in Clinical Trials Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of CRO in Clinical Trials, Headquarters and Area Served
 Table 22. Global Key Players of CRO in Clinical Trials, Product and Application
 Table 23. Global Key Players of CRO in Clinical Trials, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global CRO in Clinical Trials Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global CRO in Clinical Trials Revenue Market Share by Type (2019-2024)
 Table 27. Global CRO in Clinical Trials Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global CRO in Clinical Trials Revenue Market Share by Type (2025-2030)
 Table 29. Global CRO in Clinical Trials Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global CRO in Clinical Trials Revenue Market Share by Application (2019-2024)
 Table 31. Global CRO in Clinical Trials Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global CRO in Clinical Trials Revenue Market Share by Application (2025-2030)
 Table 33. North America CRO in Clinical Trials Market Size by Type (2019-2024) & (US$ Million)
 Table 34. North America CRO in Clinical Trials Market Size by Type (2025-2030) & (US$ Million)
 Table 35. North America CRO in Clinical Trials Market Size by Application (2019-2024) & (US$ Million)
 Table 36. North America CRO in Clinical Trials Market Size by Application (2025-2030) & (US$ Million)
 Table 37. North America CRO in Clinical Trials Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. North America CRO in Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
 Table 39. North America CRO in Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
 Table 40. Europe CRO in Clinical Trials Market Size by Type (2019-2024) & (US$ Million)
 Table 41. Europe CRO in Clinical Trials Market Size by Type (2025-2030) & (US$ Million)
 Table 42. Europe CRO in Clinical Trials Market Size by Application (2019-2024) & (US$ Million)
 Table 43. Europe CRO in Clinical Trials Market Size by Application (2025-2030) & (US$ Million)
 Table 44. Europe CRO in Clinical Trials Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Europe CRO in Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Europe CRO in Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
 Table 47. China CRO in Clinical Trials Market Size by Type (2019-2024) & (US$ Million)
 Table 48. China CRO in Clinical Trials Market Size by Type (2025-2030) & (US$ Million)
 Table 49. China CRO in Clinical Trials Market Size by Application (2019-2024) & (US$ Million)
 Table 50. China CRO in Clinical Trials Market Size by Application (2025-2030) & (US$ Million)
 Table 51. Asia CRO in Clinical Trials Market Size by Type (2019-2024) & (US$ Million)
 Table 52. Asia CRO in Clinical Trials Market Size by Type (2025-2030) & (US$ Million)
 Table 53. Asia CRO in Clinical Trials Market Size by Application (2019-2024) & (US$ Million)
 Table 54. Asia CRO in Clinical Trials Market Size by Application (2025-2030) & (US$ Million)
 Table 55. Asia CRO in Clinical Trials Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 56. Asia CRO in Clinical Trials Market Size by Region (2019-2024) & (US$ Million)
 Table 57. Asia CRO in Clinical Trials Market Size by Region (2025-2030) & (US$ Million)
 Table 58. Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Type (2019-2024) & (US$ Million)
 Table 59. Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Type (2025-2030) & (US$ Million)
 Table 60. Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Application (2019-2024) & (US$ Million)
 Table 61. Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Application (2025-2030) & (US$ Million)
 Table 62. Middle East, Africa, and Latin America CRO in Clinical Trials Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 63. Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
 Table 64. Middle East, Africa, and Latin America CRO in Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
 Table 65. Labcorp Company Details
 Table 66. Labcorp Business Overview
 Table 67. Labcorp CRO in Clinical Trials Product
 Table 68. Labcorp Revenue in CRO in Clinical Trials Business (2019-2024) & (US$ Million)
 Table 69. Labcorp Recent Development
 Table 70. IQVIA Company Details
 Table 71. IQVIA Business Overview
 Table 72. IQVIA CRO in Clinical Trials Product
 Table 73. IQVIA Revenue in CRO in Clinical Trials Business (2019-2024) & (US$ Million)
 Table 74. IQVIA Recent Development
 Table 75. Parexel Company Details
 Table 76. Parexel Business Overview
 Table 77. Parexel CRO in Clinical Trials Product
 Table 78. Parexel Revenue in CRO in Clinical Trials Business (2019-2024) & (US$ Million)
 Table 79. Parexel Recent Development
 Table 80. Syneos Health Company Details
 Table 81. Syneos Health Business Overview
 Table 82. Syneos Health CRO in Clinical Trials Product
 Table 83. Syneos Health Revenue in CRO in Clinical Trials Business (2019-2024) & (US$ Million)
 Table 84. Syneos Health Recent Development
 Table 85. PRA Health Sciences Company Details
 Table 86. PRA Health Sciences Business Overview
 Table 87. PRA Health Sciences CRO in Clinical Trials Product
 Table 88. PRA Health Sciences Revenue in CRO in Clinical Trials Business (2019-2024) & (US$ Million)
 Table 89. PRA Health Sciences Recent Development
 Table 90. PPD Company Details
 Table 91. PPD Business Overview
 Table 92. PPD CRO in Clinical Trials Product
 Table 93. PPD Revenue in CRO in Clinical Trials Business (2019-2024) & (US$ Million)
 Table 94. PPD Recent Development
 Table 95. ICON Company Details
 Table 96. ICON Business Overview
 Table 97. ICON CRO in Clinical Trials Product
 Table 98. ICON Revenue in CRO in Clinical Trials Business (2019-2024) & (US$ Million)
 Table 99. ICON Recent Development
 Table 100. Medpace Holdings Company Details
 Table 101. Medpace Holdings Business Overview
 Table 102. Medpace Holdings CRO in Clinical Trials Product
 Table 103. Medpace Holdings Revenue in CRO in Clinical Trials Business (2019-2024) & (US$ Million)
 Table 104. Medpace Holdings Recent Development
 Table 105. Wuxi Apptec Company Details
 Table 106. Wuxi Apptec Business Overview
 Table 107. Wuxi Apptec CRO in Clinical Trials Product
 Table 108. Wuxi Apptec Revenue in CRO in Clinical Trials Business (2019-2024) & (US$ Million)
 Table 109. Wuxi Apptec Recent Development
 Table 110. Tigermed Company Details
 Table 111. Tigermed Business Overview
 Table 112. Tigermed CRO in Clinical Trials Product
 Table 113. Tigermed Revenue in CRO in Clinical Trials Business (2019-2024) & (US$ Million)
 Table 114. Tigermed Recent Development
 Table 115. Boji Medical Technology Company Details
 Table 116. Boji Medical Technology Business Overview
 Table 117. Boji Medical Technology CRO in Clinical Trials Product
 Table 118. Boji Medical Technology Revenue in CRO in Clinical Trials Business (2019-2024) & (US$ Million)
 Table 119. Boji Medical Technology Recent Development
 Table 120. Pharmaron Company Details
 Table 121. Pharmaron Business Overview
 Table 122. Pharmaron CRO in Clinical Trials Product
 Table 123. Pharmaron Revenue in CRO in Clinical Trials Business (2019-2024) & (US$ Million)
 Table 124. Pharmaron Recent Development
 Table 125. Research Programs/Design for This Report
 Table 126. Key Data Information from Secondary Sources
 Table 127. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global CRO in Clinical Trials Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 2. Global CRO in Clinical Trials Market Share by Type: 2023 VS 2030
 Figure 3. Phase I Trial Features
 Figure 4. Phase II Trial Features
 Figure 5. Phase III Trial Features
 Figure 6. Phase IV Trial Features
 Figure 7. Global CRO in Clinical Trials Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 8. Global CRO in Clinical Trials Market Share by Application: 2023 VS 2030
 Figure 9. Pharmaceutical Case Studies
 Figure 10. Bio-pharm Case Studies
 Figure 11. Others Case Studies
 Figure 12. CRO in Clinical Trials Report Years Considered
 Figure 13. Global CRO in Clinical Trials Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global CRO in Clinical Trials Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global CRO in Clinical Trials Market Share by Region: 2023 VS 2030
 Figure 16. Global CRO in Clinical Trials Market Share by Players in 2023
 Figure 17. Global Top CRO in Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRO in Clinical Trials as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by CRO in Clinical Trials Revenue in 2023
 Figure 19. North America CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America CRO in Clinical Trials Market Share by Type (2019-2030)
 Figure 21. North America CRO in Clinical Trials Market Share by Application (2019-2030)
 Figure 22. North America CRO in Clinical Trials Market Share by Country (2019-2030)
 Figure 23. United States CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Canada CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Europe CRO in Clinical Trials Market Share by Type (2019-2030)
 Figure 27. Europe CRO in Clinical Trials Market Share by Application (2019-2030)
 Figure 28. Europe CRO in Clinical Trials Market Share by Country (2019-2030)
 Figure 29. Germany CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. France CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. U.K. CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Italy CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Russia CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Nordic Countries CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. China CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. China CRO in Clinical Trials Market Share by Type (2019-2030)
 Figure 37. China CRO in Clinical Trials Market Share by Application (2019-2030)
 Figure 38. Asia CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Asia CRO in Clinical Trials Market Share by Type (2019-2030)
 Figure 40. Asia CRO in Clinical Trials Market Share by Application (2019-2030)
 Figure 41. Asia CRO in Clinical Trials Market Share by Region (2019-2030)
 Figure 42. Japan CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. South Korea CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. China Taiwan CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Southeast Asia CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. India CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Australia CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Middle East, Africa, and Latin America CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Middle East, Africa, and Latin America CRO in Clinical Trials Market Share by Type (2019-2030)
 Figure 50. Middle East, Africa, and Latin America CRO in Clinical Trials Market Share by Application (2019-2030)
 Figure 51. Middle East, Africa, and Latin America CRO in Clinical Trials Market Share by Country (2019-2030)
 Figure 52. Brazil CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 53. Mexico CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 54. Turkey CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 55. Saudi Arabia CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 56. Israel CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 57. GCC Countries CRO in Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 58. Labcorp Revenue Growth Rate in CRO in Clinical Trials Business (2019-2024)
 Figure 59. IQVIA Revenue Growth Rate in CRO in Clinical Trials Business (2019-2024)
 Figure 60. Parexel Revenue Growth Rate in CRO in Clinical Trials Business (2019-2024)
 Figure 61. Syneos Health Revenue Growth Rate in CRO in Clinical Trials Business (2019-2024)
 Figure 62. PRA Health Sciences Revenue Growth Rate in CRO in Clinical Trials Business (2019-2024)
 Figure 63. PPD Revenue Growth Rate in CRO in Clinical Trials Business (2019-2024)
 Figure 64. ICON Revenue Growth Rate in CRO in Clinical Trials Business (2019-2024)
 Figure 65. Medpace Holdings Revenue Growth Rate in CRO in Clinical Trials Business (2019-2024)
 Figure 66. Wuxi Apptec Revenue Growth Rate in CRO in Clinical Trials Business (2019-2024)
 Figure 67. Tigermed Revenue Growth Rate in CRO in Clinical Trials Business (2019-2024)
 Figure 68. Boji Medical Technology Revenue Growth Rate in CRO in Clinical Trials Business (2019-2024)
 Figure 69. Pharmaron Revenue Growth Rate in CRO in Clinical Trials Business (2019-2024)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed

Description

The global CRO in Clinical Trials market is projected to grow from US$ 51240 million in 2024 to US$ 88230 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.5% during the forecast period.

A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries. Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others. In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor’s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).